We have previously demonstrated that epigenetic silencing of occludin, a tight junction-associated membrane protein, results in the acquisition of apoptotic resistance to various apoptogenic stimuli, causally contributing to the enhanced tumorigenicity of cancer cells. However, it remains to be examined whether occludin expression in transformed cells has an alternative impact that is important for cancer progression. Here we show that forced expression of occludin induces anoikis and promotes oxidative stress-induced premature senescence in breast carcinoma cells, which is accompanied by up-regulation of negative cell cycle regulators such as p16
Introduction
Four decades ago, the phenomenon of "replicative senescence" was described as a process leading to irreversible arrest of cell division in which metabolically active cultured human fibroblasts lost the ability to divide upon continuous subculture. (1) While "replicative senescence" is triggered by progressive telomere shortening, an indistinguishable phenotype, termed "premature senescence", can be acutely produced by a number of cell stresses, including oxidative stress, DNA damage-inducing agents, and enforced in vitro activated oncogenes. (2) Senescent cells show characteristic changes in cell morphology such as a flattened and vacuole-rich cytoplasmic shape, and biochemical characteristics such as elevated protein levels of cell cycle inhibitors, including p16 and p21, as well as the upregulation of senescence-associated β-galactosidase (SA-β-gal) activity and reciprocal negativity for the proliferation marker Ki67. (3) (4) (5) Accumulated evidence has revealed that cellular senescence terminates carcinogenesis in a variety of cancer tissues in vitro and in premalignant lesions. (5) However, the physiological relevance of acutely inducible premature senescence has remained controversial for years, in sharp contrast to the confirmed concepts that impaired or decreased responses to various apoptotic signals are associated with oncogenic transformation. (6, 7) Recent reports have now clarified that cellular senescence is an intrinsic cell stress-responsive cell cycle exit program, which is regarded as an anti-oncogenic fail-safe mechanism to prevent oncogenic activity in aged or potentially damaged cells, and a natural barrier to cancer progression. (4, 8, 9) Tight junctions (TJs) are intercellular structures in epithelial and endothelial cells, primarily playing a critical role in cell-cell adhesion. (10, 11) Occludin was the first identified requisite integral protein for the TJ, but occludin-deficient cells and animals have fully 4 developed well-organized TJs structurally. (12) (13) (14) Thus it is now well accepted that the claudin family, which has been shown to contain more than 20 members, is the main constituent of the TJ, rather than occludin. (11) We have also demonstrated that the methylator phenotype of occludin exhibits decreased cellular sensitivity to various differently triggered apoptogens, causally enhancing the tumorigenic properties of the transformed cells. (15) In addition, a growing body of evidence has indicated that cancer progression is associated with decreased and/or impaired TJ phenotypes, and that the loss of TJ-associated molecules such as occludin is generally correlated with tumor development in carcinogenesis. (15) (16) (17) (18) These findings suggest that occludin is not a simple static component of TJs but has functions in receiving and transmitting cell survival signals, eventually acting as a signal transmitter for the cells at TJs during the carcinogenic scenario.
Based on accumulating evidence concerning occludin, we investigated whether occludin expression in cancer cells had any alternative impact that was important for cancer progression. Here we demonstrate that the expression of occludin in transformed cells induces anoikis in three-dimensional culture of breast carcinoma cells. In addition, the cellular response in the event of occludin expression shows features of premature senescence, accompanied by upregulation of negative cell cycle regulators such as p16 INK4A , p21
Waf1/Cip1 , and p27
Kip1
, but not p53. Our observations support the idea that occludin expression in cancer cells is at least partially involved in a senescence-promoting mechanism that may prevent abnormal cells from entering the carcinogenic program during mammary tumorigenesis.
Materials and Methods
Cell line and transfection. AC2M2, a metastatic variant of murine breast cancer cell line SP1, and SP1 were isolated from a mammary intraductal adenocarcinoma that arose spontaneously in an 18-month-old CBA/J female retired breeder mouse. (19) AC2M2 cells were maintained in DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% FBS (Sanko Jyunyaku, Tokyo, Japan), 10 mM HEPES, 100 U/ml penicillin, and 100 μg/ml streptomycin at 37C in a humidified 5% CO 2 atmosphere.
Five g of pcDNA3.1(-)-occludin, which is a construct cloning full-length murine occludin cDNA into the response plasmid pcDNA3.1(-) (Invitrogen), was transfected into AC2M2 cells using FuGENE 6 reagent (Roche, Indianapolis, IN). G418 (Sigma, Tokyo, Japan)-resistant clones were expanded as a monoclonal population. Three weeks later, cell lines were selected to examine the strength of the expression of the introduced gene by quantitative reverse transcription (RT)-PCR and Western blot analysis. Since our preliminary experiment showed that phenotypes of the cells observed in the event of occludin overexpression were similar but not the same in at least 3 different independent clones, these cells were equally mixed to establish stably transfected cell lines and to avoid possible clonal variation. Small interfering RNA (siRNA) targeted to occludin or negative control siRNA (both from Santa Cruz Biotechnologies, Santa Cruz, CA) was also transfected into the cells using FuGENE 6 reagent (Roche).
Cell death analyses. Cell death was induced by preventing cells from adhering to the plastic of cell culture dishes. (15) In some experiments, 100 nM all-trans retinoic acid (atRA)(Sigma) was added and maintained throughout the experiments. Fragmented DNA 6 from dead cells was isolated according to a method that preferentially extracted low molecular weight cellular DNA. (15) Gel electrophoresis of the DNA samples was performed on 2.5% agarose gels and ladder formation due to fragmentation was visualized with ethidium bromide under ultraviolet illumination.
Senescence-associated β-galactosidase staining. The cells were exposed to mild oxidative stress under 25 μM H 2 O 2 for up to 5 days, and senescent cells were visualized by SA-β-gal staining. (3) The tumors that developed in the mouse subcutaneous tissue were also subjected to this assay. The cells positively stained by the specified procedures were scored using light microscopy by counting the number of cells under low magnification (x 100) in 10 separate arbitrarily selected fields in each section. In some experiments, atRA (100 nM), M, Calbiochem-Novabiochem) was added and maintained throughout the experiments. To examine the effect of a demethylating agent, the cells were treated with 5'-aza-2'deoxycytidine (5'Aza-dC, 0-5 M, Sigma) for 48 h, after which a histone deacetylase inhibitor (HDAI) or trichostatin A (TSA, 0-300 nM, Sigma) was added, followed by incubation for an additional 24 h at 37C.
RT-PCR and Southern blot analysis. Subsequent to each RT-PCR analysis, to allow for semiquantitative analysis of signal intensity, we carried out Southern blot analysis using a probe with the full-length cDNA of each gene. (15) Ribosomal RNA (rRNA) was shown to , p27 Kip1 (all from Santa Cruz), p53 (Oncogene, San Diego, CA), and -actin (Santa Cruz) proteins. The filters were then reacted with corresponding peroxidase-labeled secondary antibodies; finally, the immunoreactions were visualized using an enhanced chemiluminescence (ECL) system (GE Healthcare, Piscataway, NJ).
TUNEL assay and immunohistochemistry. Cells cultured on collagen coated-glass coverslips were subjected to the terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) assay. Apoptotic cells were visualized using an In Situ Cell Death Detection Kit (Roche). We also carried out a staining procedure other than for TdT as a negative control. For immunohistochemistry, the cells on a coverslip were reacted with the primary antibody against Ki67 (Dako Cytomation, Tokyo, Japan). Cells positively stained by the specified procedures were scored using light microscopy by counting the number of cells under low magnification (x 100) in 10 separate arbitrarily selected fields in each section.
Staining for actin filaments was done with rhodamine-phalloidin (1 unit/slide, Molecular Probes, Eugene, OR). All samples were examined with a fluorescence microscope (Zeiss, Tokyo, Japan) or a laser-scanning confocal microscope (Bio-Rad, Hercules, CA). Tumor growth in vivo. We subcutaneously injected cells of AC2M2 and its transfectant (7.5 x 10 3 cells/mouse) into mammary fat pads of syngenic 6-7-week-old female mice (CBA/J, Charles River Japan, Yokohama, Japan). (15) The handling of animals was carried out using protocols approved by the Sapporo Medical University Animal Care Facility.
Statistical analysis.
All data represent the mean  SD of at least 3 independent experiments, each in triplicate wells. Statistical differences were analyzed using the paired t test, and were considered significant when p<0.05. Breakdown of anoikis (anchorage dependency-mediated apoptotic cell death) may be a predominant contributor to oncogenic progression. (6) In addition, our previous study has shown that the various cell lines overexpressing occludin gain significant sensitivity to a number of apoptogenic stimuli. We therefore examined whether occludin overexpression promoted anoikis in AC2M2 cells (Fig. 1b) . Prior to the apoptotic stimulation, the media used for AC2M2-Vec and AC2M2-Oc cells were changed to media without FBS supplementation in the presence or absence of 1 M atRA as an apoptotic sensitizer. (20) DNA fragmentation analysis demonstrated that forced expression of occludin clearly enhanced the sensitivity to anoikis, and AC2M2 cells that had higher expression of occludin showed increased sensitivity to apoptosis (Fig. 1b) . TUNEL assay also revealed that atRA increased the sensitivity to anoikis both in AC2M2-Vec and AC2M2-Oc cells, and that occludin and atRA additively increased anoikis in AC2M2-Oc cells (Fig. 1c) . Based on our observation that occludin-specific siRNA efficiently suppressed occludin expression in AC2M2-Oc cells (Fig. 1d) , we found that the transfection with this siRNA partially but significantly inhibited occludin-mediated enhancement of cell death in occludin-expressing cells (Fig. 1c) , suggesting a direct mechanistic link between occludin expression and apoptotic sensitization. Importantly, the atRA-induced increase of apoptotic sensitivity was suppressed by siRNA-mediated silencing of occludin (Fig. 1c) , supporting our previous finding that endogenous occludin induced by atRA could enhance apoptotic sensitivity to apoptogenic stimuli. (15) Since occludin expression affects a wide variety of genes associated with the components of the apoptotic machinery, we next examined the gene-expression alterations in the event of occludin overexpression in AC2M2 cells (Fig. 1e) . Changes in the pattern of gene-expression were consistent with the gene-expression profiles determined by an apoptosis pathway-specific gene array, (15) in which occludin expression downregulated a number of apoptosis-inhibitory genes such as bcl-2 and survivin, but conversely upregulated apoptosis-inducing genes such as apaf-1and bax. Genes involved in the apoptosis-executing pathway such as caspase 3 were also affected, consistent with the altered phenotype mediated by occludin.
Results

Forced
Occludin expression induces premature senescence in AC2M2 cells. Premature senescence is a genetically encoded intrinsic fail-safe mechanism that has to be overcome by the further acquisition of oncogenic activities during carcinogenesis. (4, 8, 9) We next examined the effect of occludin on cellular senescence as assessed by determining the SA-β-gal enzymatic activity. (3) When the cells were exposed to a mild oxidative stress that was insufficient to induce apoptotic cell death even in AC2M2-Oc cells, the occludin-expressing cells exhibited prominent phenotypic alteration, showing cytoplasmic protrusions and enlarged flat morphology with multiple vacuoles (Fig. 2a) . In addition, the percentage of positive reactions to SA-β-gal activity was significantly high in AC2M2-Oc cells ( Fig. 2a and 2b) . Interestingly, SA-β-gal positive AC2M2-Oc cells were significantly decreased after treatment with occludin-specific siRNA ( Fig. 2b and 2c ), suggesting that occludin was associated with the signaling program to induce premature senescence. We should note here that AC2M2-Oc cells required 24 h for maximum reduction of occludin after being transfected with occludin-specific siRNA, and significant suppression of occludin expression was observed for 5 days (Fig. 2c) . We could not exclude the possibility that Occludin expression induces growth arrest under oxidative stress. To study the effect of occludin signaling on proliferation in AC2M2 cells, cell growth was analyzed in a time-dependent manner. Manual cell counting every 24 h up to day 6 after plating equal numbers of cells showed no significant differences in the growth and DNA synthesis rate, 12 whereas AC2M2-Oc cells that were exposed to oxidative stress demonstrated significant decreases both in the cell growth and DNA synthesis rate (Fig. 2d) Mitogen-activated protein kinase mediates the induction of senescence in occludin-expressing cells. The COOH-terminus of occludin is known to be important in its function, which is responsible for the transmission of various signaling pathways such as MAPK. (10, 11, 15, 21) Consistent with this, deletion mutants with various COOH-terminal 13 truncations (Fig. 3a) had no effects on increasing SA-β-gal positive cells in response to oxidative stress (Fig. 3b) , suggesting that the 44 amino acids (aa) at the COOH-terminal end of occludin were responsible for the regulation of cellular senescence. We next examined the signal transduction pathway(s) involved in the occludin-mediated premature senescence by using small-molecule protein kinase inhibitors designed to specifically block signal constituents of protein kinase cascades. A MAPK inhibitor (PD98059) partially but significantly abrogated the enhancement of premature senescence mediated by occludin overexpression, whereas other inhibitors such as a p38 MAPK inhibitor (SB203580) and PI3K inhibitor (LY294002) had no effect (Fig. 3c) , suggesting that active engagement of pMAPK signaling molecules was necessary to provoke the cellular senescence program as a result of the activation of occludin signaling.
Occludin signaling induces cell spreading. Accumulated evidence has demonstrated that senescent cells not only have different gene-expression patterns when compared with
reversibly arrested quiescent cells, but also display characteristic morphologic changes. (9) To determine the morphological alterations induced in AC2M2 cells by occludin overexpression, we examined the cells with phase-contrast microscopy at various times (30 min to 6 h) after plating the cells (Fig. 4a and 4b) . Cell shape was indistinguishable between AC2M2-Vec and AC2M2-Oc cells, which were regularly round, after 10 min in culture. Cytoplasmic protrusions were observed at 30 min and the cell shape became significantly different after 1 h in occludin-expressing cells. The size of the AC2M2-Oc cells increased and they became flattened after 1 h. These differences had gradually increased at 6 h after seeding the cells. After 6 h, a large number of occludin-expressing cells had actin stress fibers, though these were detected only in a few AC2M2-Vec cells (Fig. 4c ). Occludin-mediated cell spreading is partially explained by the evidence that occludin directly associates with cytoplasmic scaffolding proteins, submembrane components of TJs, thereby providing a direct linkage to the actin cytoskeleton, (11) and that morphological changes in the cells usually depend on the alterations of actin stress fiber formation. (22) Endogenous occludin is sufficient for provoking cellular senescence. To exclude the possibility that the forced expression of occludin resulted in unidentified artifacts in the cells, we next used a demethylator (5'Aza-dC) and HDAI (TSA) or retinoids that stimulated RARα to induce endogenous occludin expression in the AC2M2 cells (Fig. 5a ), in which CpG islands of the occludin promoter were shown to be densely methylated. (15) Although SA-β-gal enzymatic activity is a good marker to measure cellular senescence, positive staining using this assay has been observed in cases of cellular stress unrelated to senescence. (23) Thus, senescence was also verified by scoring for the maker Ki67. (5, 9) Either 5'Aza-dC or TSA alone or in synergy with these agents, as well as the RARα stimulant was sufficient for increasing the SA-β-gal positive cells, and conversely for decreasing the Ki67 positive cells (Fig. 5b and 5c ). Importantly, transfection of occludin-specific siRNA partially but significantly abrogated the increases of SA-β-gal positive cells and the decreases of Ki67 positivity mediated by the treatment with 5'Aza-dC/TSA and RARα. Our data suggested that the altered phenotypes induced by the treatment with these reagents were, at least in part, responsible for the endogenous reexpression of occludin.
Occludin expression induces senescent phenotype in vivo. We next investigated whether occludin could induce cellular senescence in vivo. SA-β-gal staining revealed diffuse strong positive reactivity in tumors that developed from AC2M2-Oc cells (Fig. 6a and 6b ).
Discussion
Herein we shed light on the novel functions of occludin in cancer cells, which have not hitherto been described as a consequence of occludin signaling, demonstrating that the loss of occludin expression is at least partially involved in the senescence-escape program during mammary tumorigenesis. While accumulating studies have shown the downregulation of TJ-associated proteins such as occludin during carcinogenesis in many cell types, (15) (16) (17) (18) the impact of our findings on breast cancer seems to be limited due to the fact that epigenetic silencing of occludin has not been demonstrated to occur during human breast cancer progression. However, we provided clear evidence that occludin expression in a number of transformed cells showed cellular features of premature senescence that can be triggered when cells are exposed to cell stressors. Although the underlying mechanism explaining how occludin determines the fate of cancer cells (i.e. apoptotic or senescence) in response to cell stressors remains to be clarified, it is possible that cell fate decision is made depending on the cell type, the type of cell stress, the strength and duration of the stress, and the cell-surrounding microenvironment, as well as on the integrity of tumor suppressor genes.
We found that occludin was associated with a number of apoptosis-associated genes and the components of the lipid signaling pathway such as MAPK. In support of these observations, the Ras/Raf oncogene-ERK (extracellular signal-regulated kinase)/MEK (MAPK/ERK kinase) cascade is of critical importance to show that this protein elicits growth arrest and premature senescence in a variety of cell types. (2, 24, 25) We also demonstrated that the COOH-terminal end of occludin played an important role in inducing cellular senescence. This is supported by a number of reports showing that the components of lipid signaling interact with the COOH-terminal region of occludin and mediate cell growth and 17 differentiation. (26) (27) (28) It is somewhat surprising that the TJ-associated gene occludin is able to induce premature senescence in tumor cells. Given the extensive range of physiological activities of occludin at TJs, it is feasible that occludin is not a simple static component of TJs, but has functions in receiving and transmitting cell survival signals, working as a signal transmitter located at the TJ in the cell. This explanation is supported by evidence that occludin directly associates with different types of signaling transduction, and TJ protein directly participates in the control of gene expression via the modulation of transcription machinery in the nucleus. (11, 29) Recent study has also shown that the second extracellular loop of occludin is a transforming growth factor-beta (TGF-β) receptor, and occludin regulates TGF-β type I receptor localization for efficient TGF-β-dependent dissolution of TJs during epithelial-mesenchymal transition, which is a cellular transformation crucial for the progression of many epithelial tumors. (30) Consistent with this view, the possible mechanisms underlying premature senescence with high expression of CDK inhibitors caused by forced expression of occludin appear to be explained by the signal transduction from membrane-anchored occludin to the nucleus.
Non-cytotoxic cell stress induces premature senescence that is characterized by upregulation of negative cell cycle regulators. Conversely, cell cycle inhibitors are able to provoke the senescent phenotype when, for example, they are ectopically overexpressed in early passage human diploid fibroblasts. (31) Indeed, our observations showed that occludin-mediated premature senescence was accompanied by upregulation of p16
, and p27
Kip1
. CDK inhibitors are key mediators of growth arrest in the course of premature senescence, and are implicated in DNA repair to prevent potentially damaged cells from undergoing consequent mitotic catastrophe. (9, 24) Whether upregulation of CDK inhibitors directly contributes to the senescence-associated phenotype in occludin-expressing cells remains to be determined, but it is possible that occludin provokes premature senescence, potentially associated with the enhanced expression of CDK inhibitors. On the other hand, we did not observe expression-alteration in p53 protein in the course of premature senescence, suggesting that the senescence induced by occludin signaling was mediated by p53-independent mechanisms and/or mutant p53. The functional requirements for the CDK inhibitors in the senescent state appeared to be heterogeneous in the examined conditions. (24, 25, 31) For example, a p53-independent senescence mechanism was proposed in response to hypermitogenic proto-oncogene ERBB2 signaling in breast carcinoma cells, (32) though p53 protein is believed to act as an integrator of cell signals for convergence of a broad range of different stressors. Another example was presented by SA-β-gal positivity in clinical breast cancer showing that chemotherapy-induced DNA damage was able to induce senescence in vivo, but that SA-β-gal staining was associated with low p53 staining. (33) Recently, senescent IMR90 human fibroblasts have been shown to accumulate a distinct heterochromatin structure, which is designated senescence-associated heterochromatin foci (SAHF). (34) We did not observe the characteristic features of SAHF during the experiment, and cannot presently explain this observation; however, one possibility is that a lack of intact Rb signaling (and disruption of the p53 pathway) may have limited the ability of occludin-expressing AC2M2 cells to display SAHF in response to the oxidative stress. Our explanation is supported by the fact that SAHF formation primarily depends on the integrity of the Rb pathway, and eventually involves the combined activities of the Rb/p16 INK4a pathway, p53 signaling, and the promyelocytic leukemia protein. (34) In addition, Rb is not essential for all aspects of the senescence program, including the characteristic morphological changes, the accumulation of SA-β-gal activity, and the irreversible exit from the cell cycle. (34) We observed that occludin expression in AC2M2 cells promoted oxidative stress-induced premature senescence, which apparently did not involve SAHF, whereas this was accompanied by up-regulation of negative cell cycle regulators and, importantly, withdrawal of the oxidative stress did not result in the release of cell cycle block. These features appear to be sufficient to distinguish senescence from quiescence, a nonproliferative state that is reversed in response to mitogens.
This study provides significant evidence that occludin signaling is potentially associated with premature senescence machinery. It is now well-accepted that the senescence process is an antioncogenic fail-safe mechanism that may function as a natural brake to tumor development, sharing therapeutic similarities with apoptotic machinery. (9, 35) Surprisingly, a number of reports have successfully demonstrated that DNA-damaging agents induce cellular senescence that lacks intact apoptotic responsiveness. (33, 36) We thus believe that occludin-mediated induction of cellular senescence can be applied as an anti-cancer mechanism to blunt oncogenic activity by inducing the cancer cells to exit uncontrolled cellular proliferation before expanding as a clinically relevant tumor mass. While overexpressed protein products or misfolded ones left in the endoplasmic reticulum cause cellular stress, which may consequently have an impact on intracellular signaling, a more important issue was addressed by our observation demonstrating that endogenous re-expression of occludin mediated by a synergistic effect with a demethylator and HDAI or retinoids that stimulated RAR was sufficient to provoke the senescent phenotype in breast carcinoma cells. Given the conceptual similarity to the apoptotic machinery, occludin is thus an appropriate therapeutic target even for cancer cells that do not have detectable expression of endogenous occludin. 
